Clinical Trial Update: Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 [Phase 1]

View source ↗

Summary

A Phase 1 trial in psoriasis examined how LAS41008 interacts with Monomethyl Fumarate (MMF); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LAS41008
• Monomethyl Fumarate (monomethyl fumarate)

Snippet

Sponsor: Almirall, S.A. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED